USFDA28 Jan 2025, 03:31 pm
Apitoria Pharma Pvt.Ltd., Unit 2 Receives VAI Classification from USFDA
AI Summary
Apitoria Pharma Pvt.Ltd., a wholly owned subsidiary of Aurobindo Pharma Ltd., has received an Establishment Inspection Report (EIR) classifying its Unit-2 facility as Voluntary Action Indicated (VAI) by the United States Food and Drug Administration (US FDA). The US FDA inspected the facility, located at Gaddapotharam Village IDA, Jinnaram Mandal, Sanga Reddy District, Telangana, from September 23 to 27, 2024.
Key Highlights
- Apitoria Pharma Pvt.Ltd., Unit 2 received EIR from USFDA with VAI classification
- US FDA inspected Unit-2, an APl manufacturing facility, of Apitoria Pharma Private Limited from September 23 to 27, 2024
- Unit-2 facility classified as Voluntary Action Indicated (VAI) by the US FDA